TrialBMC infectious diseases2016

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.

Gonzague Jourdain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.